Starling Oncology, Inc. Operating Lease Cost
Starling Oncology, Inc. (STLN) reported Operating Lease Cost of $2.02 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-06
- Starling Oncology, Inc. operating lease, cost for the quarter ending 2026-06-30 was $2.02M, a 7.00% decline year-over-year.
- Starling Oncology, Inc. operating lease, cost for the quarter ending 2026-03-31 was $2.14M, a 5.64% decline year-over-year.
- Starling Oncology, Inc. operating lease, cost for the quarter ending 2025-12-31 was $1.99M, a 15.17% decline year-over-year.
- Starling Oncology, Inc. operating lease, cost for the quarter ending 2025-09-30 was $2.01M, a 0.80% increase year-over-year.
- Starling Oncology, Inc. operating lease, cost for fiscal 2025 was $8.45M, a 1.26% decline from fiscal 2024.
- Starling Oncology, Inc. operating lease, cost for fiscal 2024 was $8.56M, a 13.26% increase from fiscal 2023.
- Starling Oncology, Inc. operating lease, cost for fiscal 2023 was $7.56M, a 25.89% increase from fiscal 2022.
- Starling Oncology, Inc. operating lease, cost for fiscal 2022 was $6.00M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.02M 10-Q · filed 2026-08-06 | $4.06M 10-Q · filed 2026-08-06 | $6.15M derived: sum of 3 quarters · filed 2026-08-06 | $8.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.14M 10-Q · filed 2026-05-07 | $4.13M derived: sum of 2 quarters · filed 2026-05-07 | $6.14M derived: sum of 3 quarters · filed 2026-05-07 | $8.31M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $4.00M derived: sum of 2 quarters · filed 2026-03-12 | $6.17M derived: sum of 3 quarters · filed 2026-08-06 | $8.45M 10-K · filed 2026-03-12 |
| 2025-09-30 | $2.01M 10-Q · filed 2025-11-13 | $4.18M derived: sum of 2 quarters · filed 2026-08-06 | $6.46M 10-Q · filed 2025-11-13 | $8.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.17M 10-Q · filed 2026-08-06 | $4.44M 10-Q · filed 2026-08-06 | $6.79M derived: sum of 3 quarters · filed 2026-08-06 | $8.78M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.27M 10-Q · filed 2026-05-07 | $4.62M derived: sum of 2 quarters · filed 2026-05-07 | $6.61M derived: sum of 3 quarters · filed 2026-05-07 | $8.60M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $4.34M derived: sum of 2 quarters · filed 2026-03-12 | $6.33M derived: sum of 3 quarters · filed 2026-03-12 | $8.56M 10-K · filed 2026-03-12 |
| 2024-09-30 | $1.99M 10-Q · filed 2025-11-13 | $3.98M derived: sum of 2 quarters · filed 2025-11-13 | $6.21M 10-Q · filed 2025-11-13 | $7.96M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $2.00M 10-Q · filed 2025-08-13 | $3.99M 10-Q · filed 2025-08-13 | $5.97M derived: sum of 3 quarters · filed 2025-08-13 | $7.94M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $1.99M 10-Q · filed 2025-05-14 | $3.97M derived: sum of 2 quarters · filed 2025-05-14 | $5.94M derived: sum of 3 quarters · filed 2025-05-14 | $7.78M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $3.96M derived: sum of 2 quarters · filed 2025-03-26 | $5.79M derived: sum of 3 quarters · filed 2025-03-26 | $7.56M 10-K · filed 2025-03-26 |
| 2023-09-30 | $1.97M 10-Q · filed 2024-11-13 | $3.81M derived: sum of 2 quarters · filed 2024-11-13 | $5.57M 10-Q · filed 2024-11-13 | $7.58M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $1.84M 10-Q · filed 2024-08-13 | $3.60M 10-Q · filed 2024-08-13 | $5.61M derived: sum of 3 quarters · filed 2024-08-13 | $7.19M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.76M 10-Q · filed 2024-05-14 | $3.77M derived: sum of 2 quarters · filed 2024-05-14 | $5.35M derived: sum of 3 quarters · filed 2024-05-14 | $6.60M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $3.59M derived: sum of 2 quarters · filed 2024-03-28 | $4.83M derived: sum of 3 quarters · filed 2024-03-28 | $6.00M 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.58M 10-Q · filed 2023-11-08 | $2.83M derived: sum of 2 quarters · filed 2023-11-08 | $3.99M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $1.25M 10-Q · filed 2023-08-09 | $2.42M 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $1.17M 10-Q · filed 2023-05-10 |